Delivery Order SPE2DB24D2010-SPE2DB25FZSY8

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,889.46 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a completion date of January 22, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,347.72, is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty pharmaceutical product, with a performance period through December 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML syringe kits. The delivery order, valued at $18,671.91, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,784.45, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. It is a firm fixed-price contract with a period of performance through May 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The $36,106.62 firm fixed price delivery order contract has a completion date of March 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,787.32 firm fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a performance period ending on December 11, 2024. The contract is not designated under a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,184.48, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract has a firm fixed price pricing type and an ultimate completion date of January 30, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,560.58 Firm Fixed Price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits, with an ultimate completion date of October 29, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,645.07 firm fixed-price delivery order is for 4564572066 CIMZIA 2X200 MG/ML SYRINGE KITS, with a completion date of May 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,594.97 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZSY8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,862.78 firm fixed-price contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a completion date of November 25, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/21/25, 9:52 AM